S100B
Protein S100-B
Also known as: S100B_HUMAN, S100beta
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P04271
- Gene
- S100B
- Ensembl
- ENSG00000160307
- Chromosome
- 21
- Canonical length
- 92 aa
- Protein class
- Cancer-related genes, Candidate cardiovascular disease genes, Predicted intracellular proteins, Transporters
- Subcellular location
- Nucleoplasm,Vesicles,Microtubules,Primary cilium,Basal body,Cytosol
- Secretome location
- Secreted - unknown location
OverviewNCBI Gene
The protein encoded by this gene is a member of the S100 family of proteins containing 2 EF-hand calcium-binding motifs. S100 proteins are localized in the cytoplasm and/or nucleus of a wide range of cells, and involved in the regulation of a number of cellular processes such as cell cycle progression and differentiation. S100 genes include at least 13 members which are located as a cluster on chromosome 1q21; however, this gene is located at 21q22.3. This protein may function in Neurite extension, proliferation of melanoma cells, stimulation of Ca2+ fluxes, inhibition of PKC-mediated phosphorylation, astrocytosis and axonal proliferation, and inhibition of microtubule assembly. Chromosomal rearrangements and altered expression of this gene have been implicated in several neurological, neoplastic, and other types of diseases, including Alzheimer's disease, Down's syndrome, epilepsy, amyotrophic lateral sclerosis, melanoma, and type I diabetes. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
92 residues, UniProt reviewed canonical sequence.
>P04271|S100B
1 MSELEKAMVA LIDVFHQYSG REGDKHKLKK SELKELINNE LSHFLEEIKE QEVVDKVMET
61 LDNDGDGECD FQEFMAFVAM VTTACHEFFE HELocalizationUniProt · AlphaFold · HPA
Whether an antibody against S100B can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Secreted
- Secreted
- Yes
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.35
- Highest tissue expression
- 4,757 nTPM
Expression across tissuesHPA
Tissue
- spinal cord: 4,757 nTPM
- midbrain: 2,119 nTPM
- hippocampal formation: 945 nTPM
- hypothalamus: 902 nTPM
- amygdala: 794 nTPM
- basal ganglia: 711 nTPM
Single-cell type
- schwann cells: 1,449 nCPM
- bergmann glia: 671 nCPM
- oligodendrocytes: 513 nCPM
- retinal pigment epithelial cells: 307 nCPM
- astrocytes: 256 nCPM
- melanocytes: 211 nCPM
Immune cell
- gdT-cell: 362 nTPM
- naive CD8 T-cell: 154 nTPM
- MAIT T-cell: 104 nTPM
- memory CD8 T-cell: 68 nTPM
- total PBMC: 64 nTPM
- NK-cell: 59 nTPM
Brain region
- medulla oblongata: 1,735 nTPM
- white matter: 1,695 nTPM
- cerebellum: 1,235 nTPM
- pons: 1,086 nTPM
- spinal cord: 1,057 nTPM
- basal ganglia: 827 nTPM
DiseaseUniProt · ClinVar · IEDB · PubMed
Four sources answering four different questions about S100B.
Disease | ImmuneIEDB
Conditions an epitope on S100B was assayed in.
- multiple sclerosis B cell
- autoimmune disease of central nervous system B cell
- type 1 diabetes mellitus T cell
Disease | AutoantibodyPubMed
Conditions in which antibodies against S100B are reported. Each links to that disease's full target list.
ReferencesPubMed · IEDB
Publications for S100B from three distinct lines of evidence, kept separate because they answer different questions: whether antibodies are directed at the protein, whether a B-cell epitope has been mapped on it, and whether a T-cell epitope has. Each is labelled with its source.
Reference: AutoantibodyPubMed
17 publications
- Persistent, long-term cerebral white matter changes after sports-related repetitive head impacts.
2014 · PLoS One · RCR 10.9 · 245 citations - Consequences of repeated blood-brain barrier disruption in football players.
2013 · PLoS One · RCR 8.4 · 220 citations - Brain-targeted autoimmunity is strongly associated with Long COVID and its chronic fatigue syndrome as well as its affective symptoms.
2025 · J Adv Res · RCR 4.3 · 12 citations - Is peripheral immunity regulated by blood-brain barrier permeability changes?
2014 · PLoS One · RCR 1.4 · 35 citations - Detection of brain-specific autoantibodies to myelin oligodendrocyte glycoprotein, S100beta and myelin basic protein in patients with Devic's neuromyelitis optica.
2001 · Neurosci Lett · RCR 1.1 · 43 citations
Show 12 more
- S100B and S100B autoantibody as biomarkers for early detection of brain metastases in lung cancer.
2016 · Transl Lung Cancer Res · RCR 0.9 · 26 citations - Astrocytic and neuronal biochemical markers in the sera of subjects with diabetes mellitus.
2004 · Neurosci Lett · RCR 0.7 · 29 citations - [Immune-inflammatory markers in remission after a first-episode psychosis in young patients].
2021 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.6 · 7 citations - [Features of inflammatory reactions in patients with juvenile depression with a clinically high risk of psychosis].
2023 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.4 · 2 citations - [The status of leukocyte-inhibitory system of inflammation in different age groups of patients with endogenous depression].
2021 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.4 · 4 citations - Autoantibody synthesis in primary progressive multiple sclerosis patients treated with interferon beta-1b.
2004 · J Neurol · RCR 0.3 · 13 citations - [S100B protein and autoantibodies to S100B protein in diagnostics of brain damage in craniocerebral trauma in children].
2010 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.3 · 8 citations - [Immunological and clinical aspects of the long-term stages of youth schizophrenia].
2022 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.2 · 2 citations - [Immunological predictors of acute post-stroke period].
2019 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0.1 · 2 citations - [Inflammatory factors and immunophenotypes in adjustment disorders].
2018 · Zh Nevrol Psikhiatr Im S S Korsakova · RCR 0 · 1 citations - [The association of aromatic microbial metabolites, inflammatory and autoimmune biomarkers with clinical dynamics in severe diseases of the central nervous system].
2020 · Zh Nevrol Psikhiatr Im S S Korsakova - [Immune profiles of patients with juvenile depression: association with clinically high risk of psychosis manifestation].
2025 · Zh Nevrol Psikhiatr Im S S Korsakova
Reference: B cellIEDB
2 publications
- High-Density Peptide Microarray Analysis of IgG Autoantibody Reactivities in Serum and Cerebrospinal Fluid of Multiple Sclerosis Patients.
2016 · Mol Cell Proteomics · RCR 2.5 · 66 citations - Antibody profiling identifies novel antigenic targets in spinal cord injury patients.
2016 · J Neuroinflammation · RCR 0.7 · 18 citations
Reference: T cellIEDB
1 publication
- Naturally presented HLA class I-restricted epitopes from the neurotrophic factor S100-β are targets of the autoimmune response in type 1 diabetes.
2019 · FASEB J · RCR 0.2 · 6 citations
Sources: PubMed — antigen-level antibody evidence from a custom retrieval. Records matching a controlled set of autoantibody terms (the MeSH descriptors Autoantibodies and Autoantigens, with title and abstract term variants) were obtained through NCBI E-utilities, and their titles and abstracts parsed for constructions that direct an antibody at a named protein rather than for co-occurrence. Captured names were resolved against UniProt nomenclature and each antigen adjudicated individually against the source text. IEDB — curated epitope assays from the Immune Epitope Database (Vita et al., Nucleic Acids Research 2019). Bibliographic records from PubMed and MeSH, U.S. National Library of Medicine; citation metrics from NIH iCite (Hutchins et al., PLoS Biology 2016). Titles link to PubMed; abstracts are not reproduced here. The NLM does not endorse this analysis.
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 1.73
- gnomAD pLI
- 0.04
- gnomAD missense Z
- 0.4
- DepMap mean gene effect
- 0.18
- DepMap dependency class
- none
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 3% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- adaptive thermogenesis
- astrocyte differentiation
- axonogenesis
- cell adhesion
- cellular response to hypoxia
- central nervous system development
- learning or memory
- long-term synaptic potentiation
- memory
- negative regulation of skeletal muscle cell differentiation
- positive regulation of apoptotic process
- positive regulation of canonical NF-kappaB signal transduction
- positive regulation of cell population proliferation
- positive regulation of myelination
- positive regulation of neuron differentiation
- regulation of cell shape
- regulation of neuronal synaptic plasticity
- response to anesthetic
- response to ethanol
- response to glucocorticoid
- response to methylmercury
- sympathetic neuron projection extension
Molecular functions
- calcium ion binding
- calcium-dependent protein binding
- identical protein binding
- protein homodimerization activity
- RAGE receptor binding
- S100 protein binding
- tau protein binding
- zinc ion binding
Cellular components
Protein domainsUniProt · Pfam · InterPro
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of S100B in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads S100B as an antibody target. Whether an autoantibody or antibody against S100B could matter depends on whether native S100B is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
S100B is annotated as secreted, so native S100B circulates and is directly accessible to antibodies. Secreted and cell-surface proteins are the autoantibody targets most likely to act like drugs, blocking or depleting the native protein.
Annotation status
The present source text does not explicitly label S100B as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...